TCL Archive NIH to Review Intramural Program: NCI’s Intramural Spending is 17 Percent, Higher than 11.1 Percent NIH-Wide Level March 7, 2014
TCL Archive ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies June 22, 2012
TCL Archive To Cut Colon Cancer Deaths, Reduce Barriers To Screening, NIH Panel Says February 5, 2010